Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hypertension I: Introduction01:28

Hypertension I: Introduction

653
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
653
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

433
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
433
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

698
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
698

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Bleeding-related quality of life in older adults: Psychometric evaluation of the HEmorrhage Life Impact indeX (HELIX).

Thrombosis research·2026
Same author

The Burden of Cardiovascular Disease in Older Adults.

Clinics in geriatric medicine·2026
Same author

Changes in arterial stiffness under blood pressure control are independently associated with cognitive impairment: The Systolic Blood Pressure Intervention Trial (SPRINT).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Same Patients, Different Health Care Systems-Revisited. Geriatric Care Models in the U.S., Canada, and Europe.

Journal of the American Geriatrics Society·2026
Same author

Targeted Nrf2 activation improves vascular endothelial function with aging and prevents vascular dysfunction following disuse in younger and older adults.

Free radical biology & medicine·2026
Same author

Arterial Stiffness Mechanisms and Orthostatic Hypotension in SPRINT: A Randomized Controlled Trial.

JACC. Advances·2026

相关实验视频

Updated: Jan 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K

在最老的老年人中高血压.

Mark A Supiano1, Simon B Ascher2, Michael W Rich3

  • 1Spencer Fox Eccles School of Medicine and University of Utah Center on Aging, Salt Lake City, Utah, USA.

JACC. Advances
|November 13, 2025
PubMed
概括

高血压在80岁及以上的成年人中很常见,增加了严重健康问题的风险. 本综述提出了老年病学4 Ms模型,用于最年长的成年人个性化高血压管理.

科学领域:

  • 老年医学 老年医学
  • 心血管研究研究心血管研究
  • 公共卫生 公共卫生

背景情况:

  • 高血压在80岁以上的成年人中非常普遍,对心血管疾病,中风,脏疾病和认知障碍有重大贡献.
  • 抗高血压疗法对主要心血管事件和这种人口中的认知衰退有好处.
  • 临床试验历来排除了许多最年长的老年患者由于虚弱,认知问题,并发症或养老院住院.

研究的目的:

  • 审查80岁及以上成年人高血压的流行病学,病理生理学,诊断和管理.
  • 为这群人群引入老年病学4 Ms模型作为以患者为中心的护理框架.
  • 突出在代表性不足的群体中需要进一步的研究以及抑郁症的作用.

主要方法:

  • 在最年长的老年人 (≥80岁) 中对高血压的文献综述.
  • 对流行病学数据和病理生理学的分析.
  • 讨论诊断和管理策略,包括拟议的4 Ms模型.

主要成果:

  • 高血压是最老年人患病和死亡的关键风险因素.
  • 现有证据支持抗高血压疗法,但强调从试验中排除易受伤害的子组.
  • 老年病学4 Ms模型为个性化护理提供了一个结构化的方法.
关键词:
这是一个令人丧的描述.老年病学4 Ms模型模型这种高血压,高血压.最古老的最古老的最古老的

更多相关视频

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

相关实验视频

Last Updated: Jan 6, 2026

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

18.3K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.7K

结论:

  • 个性化,以患者为中心的护理对于老年人高血压的管理至关重要.
  • 老年病学4 Ms模型为解决这一群体中高血压的复杂性提供了一个框架.
  • 进一步的研究至关重要,特别是专注于代表性不足的患者和降低处方策略.